REQUEST A DEMO
Total
USD $0.00
Search more companies

Medycyna Plus Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Lessors of Real Estate | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Solid Waste Collection | Ambulatory Health Care Services | Offices of Physicians | Offices of Dentists | Freestanding Ambulatory Surgical and Emergency Centers | All Other Miscellaneous Ambulatory Health Care Services
Full name: Medycyna Plus Sp. z o.o. Profile Updated: April 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Medycyna Plus Sp. z o.o. is an enterprise in Poland, with the main office in Wroclaw. It operates in the General Medical and Surgical Hospitals industry. It was incorporated on February 07, 2020.

Headquarters
Ul. Strzegomska 142 A
Wroclaw; Dolnoslaskie; Postal Code: 54-429

Contact Details: Purchase the Medycyna Plus Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Medycyna Plus Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Medycyna Plus Sp. z o.o. report to view the information.
Incorporation Date:
February 07, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medycyna Plus Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-11.11%
EBITDA
-11.11%
Net Profit (Loss) for the Period
-15%
Total Equity
-82.14%
Return on Equity (ROE)
-26.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?